Physician profile
Tomasz Stryjewski
NPI 1164860151
$9,776.58
in general payments reported to CMS, 2019-2025
17 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,746 · 2020: $1,351 · 2021: $1,200 · 2022: $320 · 2023: $550 · 2024: $309 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141 · Education: $17.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.40 |
| Education | $17.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Research LLC | $4,410.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,351.40 | 2020 | |
| Alimera Sciences, INC. | $1,229.57 | 2021-2023 | Iluvien, Yutiq |
| Regeneron Pharmaceuticals, INC. | $1,037.37 | 2019-2023 | |
| Alcon Vision LLC | $799.52 | 2019-2025 | Constellation |
| Samsara Vision | $262.66 | 2022-2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Carl Zeiss Meditec, INC. | $167.62 | 2024 | Veracity Surgical |
| Beaver-Visitec International, INC. | $144.09 | 2022 | |
| Astellas Pharma US INC | $120.14 | 2023 | |
| Abbvie INC. | $51.32 | 2022-2024 | |
| Apellis Pharmaceuticals, INC. | $51.00 | 2023-2024 | Syfovre |
| Takeda Pharmaceuticals U.S.A., INC. | $36.87 | 2024-2025 | Entyvio |
| Mallinckrodt Hospital Products INC. | $34.99 | 2025 | Acthar |
| Genentech USA, INC. | $29.40 | 2023 | Vabysmo |
| Bausch & Lomb Americas INC. | $17.97 | 2025 | Xiidra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $16.71 | 2024 | Eylea Hd |
| Eyepoint US, INC. | $15.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tomasz Stryjewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.